IFNG and neoplasm: Cytokines such as TNF-α, IFN-γ, and IL-12 released from lysed tumor cells can engage cytokine receptors on natural killer (NK) and CD8+ T cells, promoting destruction of tumor cells that downregulate major histocompatibility complex (MHC) antigen-presentation molecules and tumor cells expressing neoantigens, respectively [2].